Terminology Service for NFDI4Health
All individuals in LOINC
| Label | Id | Description |
|---|---|---|
| Ampicillin:PrThr:Pt:Ser/Plas:Ord | 43883-8 | |
| Ampicillin:PrThr:Pt:Urine:Ord | 43884-6 | |
| Ampicillin:Susc:Pt:Isolate:OrdQn | 18864-9 | |
| Ampicillin:Susc:Pt:Isolate:OrdQn:Agar diffusion | 29-9 | |
| Ampicillin:Susc:Pt:Isolate:OrdQn:Gradient strip | 6979-9 | |
| Ampicillin:Susc:Pt:Isolate:OrdQn:MIC | 28-1 | |
| Ampicillin:Susc:Pt:Isolate:Qn:MLC | 27-3 | |
| Ampicillin:Titr:Pt:Isolate+Ser:Qn:SBT | 30-7 | |
| AmpicillinSusc|Isolate | LG41011-4 | |
| Ampicillin^peak | LP307849-2 | |
| Ampicillin^peak:MCnc:Pt:Ser/Plas:Qn | 33562-0 | |
| Ampicillin^trough | LP307850-0 | |
| Ampicillin^trough:MCnc:Pt:Ser/Plas:Qn | 33919-2 | |
| Amplification/Sequencing | LP6125-1 | |
| Amprenavir | LP21307-1 | |
| Amprenavir | MTHU013842 | |
| Amprenavir | Isolate | Antibiotic susceptibilities | LP380314-7 | |
| Amprenavir | Serum or Plasma | Drug toxicology | LP389142-3 | |
| Amprenavir or Fosamprenavir | LP64721-1 | |
| Amprenavir or Fosamprenavir | MTHU026518 |